Navigation Links
Preventing Osteoporosis

Osteoporosis is a chronic, progressive disorder where there is a loss of normal bone density. A new study shows that the drug // alendronate if taken daily for 10 years can increase bone density in postmenopausal women. Drugs, such as alendronate, have been used for years to treat osteoporosis.

The research began with a three-year study on women taking the drug or a placebo. Women on the drug continued to receive the drug for the next two years. Then for the next five years, women on 5 milligrams or 10 milligrams of the drug continued with the drug at the same dose, while another group of women received 20 milligrams of the drug for two years. That was followed by 5 milligrams of the drug for three years and then a placebo for the next five years. Researchers say 247 women stayed with the study for the entire 10 years.

The study showed women on 10 milligrams of alendronate daily increased their bone density compared to women not on the drug. Women on 5 milligrams had smaller gains than women on 10 milligrams. In addition, researchers say women who were on the drug and then taken off of it had a gradual loss of their improvements in their bone density.

Thus researchers say continuous treatment of 10 milligrams of alendronate appears to be the best treatment for postmenopausal women and the key is staying on the drug because once you go off of it the benefits start to diminish.
'"/>




Page: 1

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Preventing Childhood Deaths
4. Preventing Vision Loss
5. Preventing Vision Loss
6. Preventing Colorectal Cancer
7. Preventing Prostate Cancer
8. Lycopene Can Help In Preventing Prostate Cancer
9. Heart Drug Also Effective In Preventing Specific Causes Of Death
10. Preventing cavities in children
11. Preventing Strokes Using Less Invasive Techniques

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Preventing Osteoporosis

(Date:11/24/2009)....24/PRNewswire/--Whiletheholidayseasonoftenbringsf...yearcanbedifficultforthosegrievingthedeathofaloved...andfamilies.Theholidayseasoncanbringadditionalchal...ngPlace,ACenterforGrievingChildren,AdolescentsandT...dditiontohavingavarietyofprintandonlineresourcesav...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--HealthSouthCorpora...heBankofAmericaMerrillLynch2009CreditConferenceinN...residentandTreasurerEdFaywillbespeakingonThursday,...stliveandwillbeavailableat http://investor.healths...HealthSouth ,, HealthSouthisthenation,slargest...
(Date:11/24/2009)...s didn,t differ greatly between high- and low-volu.... 24 (HealthDay News) -- Do hospitals that conduct...st results for patients? Maybe not. , Prior res...when it comes to artery-opening procedures, but a ...- and high-volume hospitals performing more or les...
(Date:11/24/2009)...a,Nov.24/PRNewswire-FirstCall/-HardtoTreatDiseases...gsubsidiarySlavicaBioChem,isprovidingthisbriefupda...inuesduediligencewiththeEUstemcellcompanyandmerger...oraboutOct29,2009whichthecompanymade. http://www.p...News . ,, HTDSandSlavicaBiochemarealsodiscussin...
(Date:11/24/2009)...24/PRNewswire/--Metastorm,aleadingproviderofBusine...PA),andEnterpriseArchitecture(EA)softwareforaligni...merisourceBergenCorporation,oneoftheworld,slargest...rdforNorthAmericainthe2009GlobalAwardsforExcellenc...implementationofMetastorm,sBPMsoftware.Theawardrec...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2
...arch 5 AmericInn(R) International, LLC officially...,s new sleep advocacy and awareness campaign, with.... The new Web portal is designed to educate consum...ter America" Web site centralizes unique sleep-rel...
... 3, 2009) - How messages sent within stem cells th... the cells to specialize and become blood cells in...McMaster Stem Cell and Cancer Research Institute. ...way, known as the noncanonical Wnt, in inducing bl...
...lternative Reproductive Resources (ARR) today ann...economic realities given the investment required f... Alternatives ," it offers incentive pricing to in...ome egg donors," said Robin von Halle, president o...
...cabbage block protein in disease spread, study say...- A drug based on compounds extracted from crucife... offer a potent and safe treatment against melanom...production and blocked the signaling network of a ...
... and Asia to Realize New Executive Leadership , ,...okyo Stock Exchange), a leading medical diagnosti...ion systems developer, today announced executive l... Sysmex Corporate after a six-year tenure in the U...
...clinical trial involving more than 3,000 women in ...first time the promise of a vaginal microbicide ge... to findings presented at the Conference on Retrov...30% effective. While the results are encouraging, ...
Other Medicine News:Health News:AmericInn Hotels Kicks-Off 'Sleep Better America' With Launch of New Web Site to Educate Consumers About Insomnia and Sleep-Related Issues 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Clinical trial finds microbicide promising as HIV prevention method for women 2
(Date:11/24/2009)...-FirstCall/--CardioGenicsHoldingsInc.(OTCBulletinB...ingtheimmunoassaysegmentoftheIVDtestingmarket,repo...ngtothenextphaseofthecommercializationofCardioGeni..."). ,, PertheagreementwithMerckChimiethatwasexe...iewithitsproprietarysilvercoatedparamagneticbeadsf...
(Date:11/24/2009)...--NeurocrineBiosciences,Inc.(Nasdaq: NBIX )announc...fficerofNeurocrineBiosciences,willbepresentingatth...rk. ,, ThelivepresentationtakesplaceTuesday,Dec...icTime(PT).Thepresentationwillbesimultaneouslywebc...www.neurocrine.com . ,, Ifyouareunabletoattendt...
(Date:11/24/2009)...stCall/--IsisPharmaceuticals,Inc.(Nasdaq: ISIS ),t...managementwillpresentacompanyoverviewatPiperJaffra...r1,2009,at10:30a.m.ETatTheNewYorkPalaceHotel. ,...eonthe"Investors&Media"sectionoftheCompany,sWe...willbeavailableontheIsisWebsitewithin48hoursandwil...
Breaking Medicine Technology:CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 2CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads 3FSU researcher wins 242 4M in grants to pursue early detection of autism 59560 1FSU researcher wins 242 4M in grants to pursue early detection of autism 59560 2FSU researcher wins 242 4M in grants to pursue early detection of autism 59560 3Smoking Bans Good for Non Smokers Hearts 3A Study 59559 1Smoking Bans Good for Non Smokers Hearts 3A Study 59559 2Smoking Bans Good for Non Smokers Hearts 3A Study 59559 3Smoking Bans Reduce Heart Attacks 3A Study 59555 1Smoking Bans Reduce Heart Attacks 3A Study 59555 2Smoking Bans Reduce Heart Attacks 3A Study 59555 3
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
...ay Provide Cancer Patients With Improved Potential...16, 2007 /PRNewswire/ -- Insert,Therapeutics, Inc....h Corporation announced today its novel delivery s...oster presentation at,the 2007 American Associatio...rticular, this poster includes new research findin...
Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
Graftech Cervical Spacer
Neuroclip Cranial Flap Fixation System
Timesh 1.6
Craniofix Titanium Clamp
Medicine Products: